A Prospective Study on the Efficacy of Cognitive Targeted Transrectal Ultrasound Prostate Biopsy in Diagnosing Clinically Significant Prostate Cancer

References

• Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–1092. doi:10.1016/j.eururo.2012.02.054
   PubMed Web of Science ®Google Scholar
• Villers A, Grosclaude P. Epidemiology of prostate cancer: review article. Nuclear medicine. 2008 Jan 1; 32 (1): 2-4.
   Google Scholar
• Carter HB, Hamper UM, Sheth S, Sanders RC, Epstein JI, Walsh PC. Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol. 1989;142(4):1008–1010. doi:10.1016/S0022-5347[17]38971-1
   Web of Science ®Google Scholar
• Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol. 2015;68(3):438–450. doi:10.1016/j.eururo.2014.11.037
   PubMed Web of Science ®Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer [PROMIS]: a paired validating confirmatory study. Lancet. 2017;389(10071):815–822. doi:10.1016/S0140-6736[16]32401-1
   PubMed Web of Science ®Google Scholar
• Porpiglia F, Manfredi M, Mele F, et al. Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate Cancer. Eur Urol. 2017;72(2):282–288. doi:10.1016/j.eururo.2016.08.041
   PubMed Web of Science ®Google Scholar
• Tonttila PP, Lantto J, Pääkkö E, et al. Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy-naive men with suspected prostate cancer based on elevated prostate-specific antigen values: results from a Randomized Prospective Blinded Controlled Trial. Eur Urol. 2016;69(3):419–425. doi:10.1016/j.eururo.2015.05.024
   PubMed Web of Science ®Google Scholar
• Boesen L, Noergaard N, Chabanova E, et al. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand J Urol. 2015;49(1):25–34. doi:10.3109/21681805.2014.925497
   PubMed Web of Science ®Google Scholar
• Siddiqui MM, Rais-Bahrami S, Truong H, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013;64(5):713–719. doi:10.1016/j.eururo.2013.05.059
   PubMed Web of Science ®Google Scholar
• Jain S, Saxena S, Kumar A. Epidemiology of prostate cancer in India. Meta Gene. 2014;2:596–605. doi:10.1016/j.mgene.2014.07.007
   PubMedGoogle Scholar
• Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378(19):1767–1777. doi:10.1056/NEJMoa1801993
   PubMed Web of Science ®Google Scholar
• van der Leest M, Cornel E, Israël B, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective Multicenter Clinical Study. Eur Urol. 2019;75(4):570–578. doi:10.1016/j.eururo.2018.11.023
   PubMed Web of Science ®Google Scholar
• Bansal S, Gupta NP, Yadav R, et al. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion prostate biopsy: a prospective, single centre study. Indian J Urol. 2017;33(2):134–139. doi:10.4103/0970-1591.203414
   Web of Science ®Google Scholar
• Roethke MC, Kuru TH, Schultze S, et al. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol. 2014;24(2):344–352. doi:10.1007/s00330-013-3017-5
   PubMed Web of Science ®Google Scholar
• Rouvière O, Puech P, Renard-Penna R, et al. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients [MRI-FIRST]: a prospective, multicentre, paired diagnostic study. Lancet Oncol. 2019;20(1):100–109. doi:10.1016/S1470-2045(18)30569-2
   PubMed Web of Science ®Google Scholar
• Sonn GA, Natarajan S, Margolis DJA, et al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol. 2013;189(1):86–92. doi:10.1016/j.juro.2012.08.095
   PubMed Web of Science ®Google Scholar
• Yacoub JH, Verma S, Moulton JS, Eggener S, Oto A. Imaging-guided prostate biopsy: conventional and Emerging Techniques. Radiographics. 2012;32(3):819–837. doi:10.1148/rg.323115053
   PubMed Web of Science ®Google Scholar
• Marks L, Young S, Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol. 2013;23(1):43–50. doi:10.1097/MOU.0b013e32835ad3ee
   PubMed Web of Science ®Google Scholar
• Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology. 2011 May 1;77(5):1035-41.
   Google Scholar
• Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002 Nov 1;60(5):826-30.
   Google Scholar
• Carmignani L, Picozzi S, Spinelli M, et al. Bacterial sepsis following prostatic biopsy. Int Urol Nephrol. 2012;44(4):1055–1063. doi:10.1007/s11255-012-0145-9
   Web of Science ®Google Scholar
• Khoddami M, Khademi Y, Aghdam MK, et al. Correlation between Gleason scores in needle biopsy and corresponding radical prostatectomy specimens: a twelve-year review. Iran J Pathol. 2016;11(2):120.
   Google Scholar
• Divrik RT, Erogˇlu A, Şahin A, Zorlu F, Özen H. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. InUrologic Oncology: Seminars and Original Investigations 2007 Sep 1 (Vol. 25, No. 5, pp. 376-382). Elsevier.
   Google Scholar